Nutex Health Inc. (NUTX) insider trading.
In Q3 2026, insiders at Nutex Health Inc. reported 5 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $43K.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 1
- Net shares, P minus S
- -203
- Insiders
- 4
- Last filed
- 2026-09-18
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Saunders Scott J | Director | 2 | 0 | 1 |
| Jaumot Frank E | Director | 1 | 0 | 0 |
| Grenas Cheryl Yvonne | Director | 1 | 0 | 0 |
| Reed Michael Lee | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-18 | Saunders Scott J | S (D) | 203 | $214.25 | 400 | Form 4 |
| 2026-07-31 | Jaumot Frank E | M (A) | 603 | $0 | 753 | Form 4 |
| 2026-07-31 | Grenas Cheryl Yvonne | M (A) | 603 | $0 | 670 | Form 4 |
| 2026-07-31 | Reed Michael Lee | M (A) | 603 | $0 | 670 | Form 4 |
| 2026-07-31 | Saunders Scott J | M (A) | 603 | $0 | 603 | Form 4 |
Transaction codes in this quarter
Get NUTX insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1479681&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · NUTX company page · Nutex Health Inc. on SEC.gov
Questions
Are insiders buying or selling Nutex Health Inc. (NUTX)?
In Q3 2026, insiders at Nutex Health Inc. reported 5 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $43K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Nutex Health Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/nutx.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.